Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.58 |
| ▸ | TSHR | P16473 | 3/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | CASP6 | P55212 | 2/20 | 0.49 |
| ▸ | CASP1 | P29466 | 1/20 | 0.49 |
| ▸ | CASP3 | P42574 | 1/20 | 0.49 |
| ▸ | CASP4 | P49662 | 1/20 | 0.49 |
| ▸ | CASP7 | P55210 | 1/20 | 0.49 |
| ▸ | CASP9 | P55211 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | ACHE | P22303 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | PTPRC | P08575 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6939141 | 0.80 | ALDH1A1 (0.47) | ALDH1A1TDP1TSHRCYP3A4NPC1 | |
| SCHEMBL6140569 | 0.78 | TDP1 (0.60) | ALDH1A1TDP1TSHRCYP3A4NPC1 | |
| SCHEMBL2627310 | 0.76 | ALDH1A1 (0.55) | ALDH1A1TDP1TSHRCYP3A4NPC1 | |
| SCHEMBL10885870 | 0.76 | RECQL (0.59) | ALDH1A1TDP1TSHRMAPK1SMN1; SMN2 | |
| SCHEMBL12556877 | 0.76 | TDP1 (0.56) | ALDH1A1TDP1TSHRCYP3A4NPC1 | |
| SCHEMBL6140258 | 0.76 | TDP1 (0.69) | ALDH1A1TDP1TSHRCYP3A4NPC1 | |
| SCHEMBL10126926 | 0.76 | ALDH1A1 (0.69) | ALDH1A1TDP1TSHRCYP3A4NPC1 | |
| SCHEMBL242441 | 0.75 | GAA (0.69) | ALDH1A1CYP3A4SMN1; SMN2CYP1A2MAPT | |
| SCHEMBL6221391 | 0.75 | GAA (0.69) | ALDH1A1CYP3A4SMN1; SMN2CYP1A2MAPT | |
| SCHEMBL7049102 | 0.75 | GAA (0.60) | ALDH1A1TDP1TSHRCYP3A4SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9272056-B2 | Method to produce hyperpolarised carboxylates | GE HEALTHCARE AS (NO) | 2016-03-01 | — | — | US | disclosed |
| US-9272056-B2 | Method to produce hyperpolarised carboxylates | GE HEALTHCARE AS (NO) | 2016-03-01 | — | — | US | disclosed |
| US-9272056-B2 | Method to produce hyperpolarised carboxylates | GE HEALTHCARE AS (NO) | 2016-03-01 | — | — | US | disclosed |
| US-8951502-B2 | Method of dynamic nuclear polarisation (DNP) | GE HEALTHCARE AS (NO) | 2015-02-10 | — | — | US | disclosed |
| EP-1962912-B1 | METHOD TO PRODUCE HYPERPOLARISED CARBOXYLATES OF ORGANIC AMINES | GE HEALTHCARE AS (NO) | 2012-09-26 | — | — | EP | disclosed |
| US-20100233096-A1 | METHOD TO PRODUCE HYPERPOLARISED CARBOXYLATES AND SULPHONATES | LERCHE MATHILDE H | 2010-09-16 | — | — | US | disclosed |
| US-20100233096-A1 | METHOD TO PRODUCE HYPERPOLARISED CARBOXYLATES AND SULPHONATES | LERCHE MATHILDE H | 2010-09-16 | — | — | US | disclosed |
| US-20100233096-A1 | METHOD TO PRODUCE HYPERPOLARISED CARBOXYLATES AND SULPHONATES | LERCHE MATHILDE H | 2010-09-16 | — | — | US | disclosed |
| US-20090238768-A1 | MULTIMERIC MAGNETIC RESONANCE CONTRAST AGENTS | AXELSSON OSKAR | 2009-09-24 | — | — | US | disclosed |
| US-20090238768-A1 | MULTIMERIC MAGNETIC RESONANCE CONTRAST AGENTS | AXELSSON OSKAR | 2009-09-24 | — | — | US | disclosed |
| US-20090238768-A1 | MULTIMERIC MAGNETIC RESONANCE CONTRAST AGENTS | AXELSSON OSKAR | 2009-09-24 | — | — | US | disclosed |
| US-20080292551-A1 | Method to Produce Hyperpolarised Carboxylates | GE HEALTHCARE AS (NO) | 2008-11-27 | — | — | US | disclosed |
| US-20080292551-A1 | Method to Produce Hyperpolarised Carboxylates | GE HEALTHCARE AS (NO) | 2008-11-27 | — | — | US | disclosed |
| US-20080292551-A1 | Method to Produce Hyperpolarised Carboxylates | GE HEALTHCARE AS (NO) | 2008-11-27 | — | — | US | disclosed |
| US-20080260649-A1 | Method of Dynamic Nuclear Polarisation DNP | GE HEALTHCARE AS (NO) | 2008-10-23 | — | — | US | disclosed |
| EP-1960393-A1 | MULTIMERIC MAGENTIC RESONANCE CONTRAST AGENTS | GE Healthcare AS (NO) | 2008-08-27 | — | — | EP | disclosed |
| EP-1954321-A2 | METHOD OF DYNAMIC NUCLEAR POLARISATION (DNP) USING A TRITYL RADICAL AND A PARAMAGNETIC METAL ION | GE Healthcare AS (NO) | 2008-08-13 | — | — | EP | disclosed |
| WO-2007064227-A1 | MULTIMERIC MAGENTIC RESONANCE CONTRAST AGENTS | GE HEALTHCARE AS (NO) | 2007-06-07 | — | — | WO | disclosed |
| WO-2007064227-A1 | MULTIMERIC MAGENTIC RESONANCE CONTRAST AGENTS | GE HEALTHCARE AS (NO) | 2007-06-07 | — | — | WO | disclosed |
| WO-2007064226-A2 | METHOD OF DYNAMIC NUCLEAR POLARISATION (DNP) USING A TRITYL RADICAL AND A PARAMAGNETIC METAL ION | GE HEALTHCARE AS (NO) | 2007-06-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080260649-A1 | Method of Dynamic Nuclear Polarisation DNP | DYRK4, NDC1, MT-ND4L | ALDH1A1 4857/4885TDP1 2408/4885TSHR 897/4885 |
| US-20100233096-A1 | METHOD TO PRODUCE HYPERPOLARISED CARBOXYLATES AND SULPHONATES | CA6, SLC35B2, CA3 | ALDH1A1 1865/4885TDP1 4582/4885TSHR 1909/4885 |
| US-20090238768-A1 | MULTIMERIC MAGNETIC RESONANCE CONTRAST AGENTS | MAG, MSR1, FABP7 | ALDH1A1 2448/4885TDP1 4003/4885TSHR 3937/4885 |
| US-20080292551-A1 | Method to Produce Hyperpolarised Carboxylates | PAM, OAT, TSPO | ALDH1A1 2321/4885TDP1 4367/4885TSHR 558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.